These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 26523837)

  • 41. A close collaboration of chitosan with lipid colloidal carriers for drug delivery applications.
    Bugnicourt L; Ladavière C
    J Control Release; 2017 Jun; 256():121-140. PubMed ID: 28414148
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cisplatin-loaded polymeric nanoparticles: characterization and potential exploitation for the treatment of non-small cell lung carcinoma.
    Shi C; Yu H; Sun D; Ma L; Tang Z; Xiao Q; Chen X
    Acta Biomater; 2015 May; 18():68-76. PubMed ID: 25707922
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Drug/Dye-Loaded, Multifunctional PEG-Chitosan-Iron Oxide Nanocomposites for Methotraxate Synergistically Self-Targeted Cancer Therapy and Dual Model Imaging.
    Lin J; Li Y; Li Y; Wu H; Yu F; Zhou S; Xie L; Luo F; Lin C; Hou Z
    ACS Appl Mater Interfaces; 2015 Jun; 7(22):11908-20. PubMed ID: 25978458
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Development and characterization of a new plasmid delivery system based on chitosan-sodium deoxycholate nanoparticles.
    Cadete A; Figueiredo L; Lopes R; Calado CC; Almeida AJ; Gonçalves LM
    Eur J Pharm Sci; 2012 Mar; 45(4):451-8. PubMed ID: 21986445
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intracellular siRNA delivery dynamics of integrin-targeted, PEGylated chitosan-poly(ethylene imine) hybrid nanoparticles: A mechanistic insight.
    Ragelle H; Colombo S; Pourcelle V; Vanvarenberg K; Vandermeulen G; Bouzin C; Marchand-Brynaert J; Feron O; Foged C; Préat V
    J Control Release; 2015 Aug; 211():1-9. PubMed ID: 25989603
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A Comprehensive Physicochemical, In Vitro and Molecular Characterization of Letrozole Incorporated Chitosan-Lipid Nanocomplex.
    Azandaryani AH; Kashanian S; Shahlaei M; Derakhshandeh K; Motiei M; Moradi S
    Pharm Res; 2019 Mar; 36(4):62. PubMed ID: 30850895
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Development and characterisation of chitosan films impregnated with insulin loaded PEG-b-PLA nanoparticles (NPs): a potential approach for buccal delivery of macromolecules.
    Giovino C; Ayensu I; Tetteh J; Boateng JS
    Int J Pharm; 2012 May; 428(1-2):143-51. PubMed ID: 22405987
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Investigation on novel chitosan nanoparticle-aptamer complexes targeting TGF-β receptor II.
    Chen X; Zhu X; Li L; Xian G; Wang W; Ma D; Xie L
    Int J Pharm; 2013 Nov; 456(2):499-507. PubMed ID: 23999222
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Polymer-lipid hybrid systems: merging the benefits of polymeric and lipid-based nanocarriers to improve oral drug delivery.
    Rao S; Prestidge CA
    Expert Opin Drug Deliv; 2016; 13(5):691-707. PubMed ID: 26866382
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Oxaliplatin immuno hybrid nanoparticles for active targeting: an approach for enhanced apoptotic activity and drug delivery to colorectal tumors.
    Tummala S; Gowthamarajan K; Satish Kumar MN; Wadhwani A
    Drug Deliv; 2016 Jun; 23(5):1773-87. PubMed ID: 26377238
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Natural extracts into chitosan nanocarriers for rosmarinic acid drug delivery.
    da Silva SB; Amorim M; Fonte P; Madureira R; Ferreira D; Pintado M; Sarmento B
    Pharm Biol; 2015 May; 53(5):642-52. PubMed ID: 25489634
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mad2 checkpoint gene silencing using epidermal growth factor receptor-targeted chitosan nanoparticles in non-small cell lung cancer model.
    Nascimento AV; Singh A; Bousbaa H; Ferreira D; Sarmento B; Amiji MM
    Mol Pharm; 2014 Oct; 11(10):3515-27. PubMed ID: 25256346
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy.
    Min KH; Park K; Kim YS; Bae SM; Lee S; Jo HG; Park RW; Kim IS; Jeong SY; Kim K; Kwon IC
    J Control Release; 2008 May; 127(3):208-18. PubMed ID: 18336946
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Anti-tumor efficacy of hyaluronan-based nanoparticles for the co-delivery of drugs in lung cancer.
    Jeannot V; Gauche C; Mazzaferro S; Couvet M; Vanwonterghem L; Henry M; Didier C; Vollaire J; Josserand V; Coll JL; Schatz C; Lecommandoux S; Hurbin A
    J Control Release; 2018 Apr; 275():117-128. PubMed ID: 29474960
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Systemic delivery of micelles loading with paclitaxel using N-succinyl-palmitoyl-chitosan decorated with cRGDyK peptide to inhibit non-small-cell lung cancer.
    Yuan ZQ; Li JZ; Liu Y; Chen WL; Yang SD; Zhang CG; Zhu WJ; Zhou XF; Liu C; Zhang XN
    Int J Pharm; 2015 Aug; 492(1-2):141-51. PubMed ID: 26188316
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tumor-targeting glycol chitosan nanoparticles as a platform delivery carrier in cancer diagnosis and therapy.
    Lee SJ; Min HS; Ku SH; Son S; Kwon IC; Kim SH; Kim K
    Nanomedicine (Lond); 2014 Aug; 9(11):1697-713. PubMed ID: 25321170
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Self-assembled nanoparticles containing hydrophobically modified glycol chitosan for gene delivery.
    Yoo HS; Lee JE; Chung H; Kwon IC; Jeong SY
    J Control Release; 2005 Mar; 103(1):235-43. PubMed ID: 15710514
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chitosan nanoparticles for siRNA delivery: optimizing formulation to increase stability and efficiency.
    Ragelle H; Riva R; Vandermeulen G; Naeye B; Pourcelle V; Le Duff CS; D'Haese C; Nysten B; Braeckmans K; De Smedt SC; Jérôme C; Préat V
    J Control Release; 2014 Feb; 176():54-63. PubMed ID: 24389132
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The close correlation between 8-hydroxy-2'-deoxyguanosine and epidermal growth factor receptor activating mutation in non-small cell lung cancer.
    Kawahara A; Azuma K; Hattori S; Nakashima K; Basaki Y; Akiba J; Takamori S; Aizawa H; Yanagawa T; Izumi H; Kohno K; Kono S; Kage M; Kuwano M; Ono M
    Hum Pathol; 2010 Jul; 41(7):951-9. PubMed ID: 20236686
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cancer-targeted MDR-1 siRNA delivery using self-cross-linked glycol chitosan nanoparticles to overcome drug resistance.
    Yhee JY; Song S; Lee SJ; Park SG; Kim KS; Kim MG; Son S; Koo H; Kwon IC; Jeong JH; Jeong SY; Kim SH; Kim K
    J Control Release; 2015 Jan; 198():1-9. PubMed ID: 25481438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.